Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

NCT05039281 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma
Recurrent Gliosarcoma

Interventions

BIOLOGICAL: Atezolizumab
DRUG: Cabozantinib

Sponsor

M.D. Anderson Cancer Center